Escolar Documentos
Profissional Documentos
Cultura Documentos
Regional anesthesia - regional analgesia - spinal, epidural, plexus block. analgesia is altered sensation of
painful stimuli, but can feel movement and pressure.
GA
5 phases- preparation, induction, maintanence, emergence ( patient start regain brainstem function first,
breathing, coughing, shivering, then cerebral cortex purposeful movements, respond to command), recovery
indication
- surgical ( need muscle relaxation - abdominal surgery, inability to comfort with LA, RA, duration more
than 3 hours
- patient ( need airway protection, respiratory failure, unstable clinical state)
Type of induction
1. IV induction ( Porpofol, etomidate, ketamine, midazolam) sedative-hypnotic agents
default method starting GA
100% O2 before, during and after
Propofol activates GABA channel. - open Cl channel and causes Cl enter cells, lowers the depolarisation
threshold in cells.
method- preoxygenation is critical. propofol. cricoid pressure. muscle relaxant. ETT insert.
Inhalaation agent act at the level of CNS by disrupting normal synaptic transmission.
1. interfere release of neurotransmitter from presynaptic nerve terminal
2. alter the re uptake of neurotransmitter
3. changing binding of neurotransmitter to post synaptic sites
Effect on respi - All agents increase threshold of respi centres to CO2. isoflurane and sevoflurane decrease
airway resistance, desflurane does not produce significant change in bronchial tone.
Effect on CVS - Sevoflurane may prolong QT interval. Arryhythmogenic potential of sevoflurane and
desflurane is lower than isoflurane.
MUSCLE RELAXANT
Indication: laryngeal intubation and RSI , abdominal muscle relaxation during laparotomy
Depolaring NMB - suxamethonium block postsynaptic receptors on skeletal muscle. side effects: malignant
hyperpyrexia, increased IOP, muscular pain, massive rise in potassium
Non depolarising - rocuronium block postsynaptic receptors on skeletal muscle but does not cause
depolarisation. side effects- bronchospams, allergic
LA- membrane stablizing drugs - slow down speed of AP , ultimately stopping AP generation
injectable - low potent short duration - procaine, intermediate potency - lidocaine, high potency and long
duration - tetracaine, bupivacaine